Opinion
Trace Dominguez on MSNOpinion

Genetically Altered Humans Born in China: What It Means for the Future

Editing human DNA has moved from theory to reality, leaving the world to face difficult questions about the future.

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.